Danaher Corporation NYQ · DHR
Price alert —
Sign in to get a one-time email the moment DHR crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · DHR
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6.0B | $1.0B | $1.3B | $1.1B | 17.3% | 22.6% |
| 2025-12-31 | $6.8B | $1.2B | $1.5B | $1.7B | 17.5% | 22.0% |
| 2025-09-30 | $6.1B | $0.9B | $1.2B | $1.4B | 15.0% | 19.1% |
| 2025-06-30 | $5.9B | $0.6B | $0.8B | $1.1B | 9.3% | 12.8% |
| 2025-03-31 | $5.7B | $1.0B | $1.3B | $1.1B | 16.6% | 22.2% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare DHR vs peers
Line DHR up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with DHR
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 0 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
No earnings history available.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| DHR ★ | $144B | 39.5 | 22.1 | 5.8 | 19.9 | 2.7 | 59.0% | 3.7% | 9.8% | 3.17% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 32.83%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 51,640,619 | 7.30% |
| Vanguard Capital Management LLC | 41,127,810 | 5.81% |
| State Street Corporation | 27,894,181 | 3.94% |
| FMR, LLC | 22,534,329 | 3.18% |
| JPMORGAN CHASE & CO | 16,917,649 | 2.39% |
| Price (T.Rowe) Associates Inc | 15,352,887 | 2.17% |
| Wellington Management Group, LLP | 14,774,524 | 2.09% |
| Geode Capital Management, LLC | 14,145,758 | 2.00% |
| Capital International Investors | 14,014,713 | 1.98% |
| Vanguard Portfolio Management LLC | 13,954,705 | 1.97% |
Insider activity · 90d
14 buys / 0 sells · ratio 14.0 · Finnhub
- Lamanna Charles W BUY 1,699
- Lamanna Charles W BUY 1,359
- Couchara Georgeann F 8,291 @ $161.91
- Sanders A Shane BUY 1,699
- Sanders A Shane BUY 5,914
- Stevens Raymond C BUY 1,699
- Stevens Raymond C BUY 13,728
- List Teri BUY 1,699
- List Teri BUY 21,470
- Dewan Feroz BUY 1,699
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
No CIK found for DHR.
About DHR
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and character…
Options picks · DHR
ITM + OTM ideas from the latest scanLoading…
Congress trades · DHR
STOCK Act disclosuresLoading…
SEC filings & insiders · DHR
EDGAR · liveLoading…
Holders · DHR
Institutions & insider activityLoading…